Related Experiment Video
Updated: Aug 8, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Ferroptosis-Related Proteins Are Potential Diagnostic Molecular Markers for Patients with Preeclampsia
Meiting Shi1, Xiaofeng Yang1, Yuzhen Ding1
1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou 510000, China.
Insights
Preeclampsia (PE) diagnosis can be improved using ferroptosis-related genes. This study identified p53 and c-Jun as key biomarkers, with c-Jun showing superior diagnostic power for early detection and treatment.
Area of Science:
- Biochemistry
- Genetics
- Reproductive Medicine
Background:
- Preeclampsia (PE) is a major cause of maternal and fetal mortality.
- Oxidative stress and ferroptosis are implicated in PE pathophysiology.
- Early diagnosis of PE is crucial for reducing mortality.
Purpose of the Study:
- To identify ferroptosis-related biomarkers for early PE diagnosis.
- To investigate the role of ferroptosis in PE pathogenesis.
- To validate the diagnostic value of identified genes in PE patients.
Main Methods:
- Analysis of gene expression datasets (GEO) to identify differentially expressed genes (DEGs).
- Utilized R package 'limma', GO, KEGG, and PPI network analysis.
- Validated key genes (p53, c-Jun) using ELISA and ROC curve analysis.
Main Results:
- Identified 5913 DEGs and 45 ferroptosis-related DEGs.
- p53 and c-Jun emerged as critical hub genes in the protein-protein interaction network.
- ELISA confirmed elevated serum p53 and decreased c-Jun in PE patients; ROC analysis showed high diagnostic accuracy (c-Jun AUC=0.87, p53 AUC=0.75).
Conclusions:
- p53 and c-Jun are potential diagnostic biomarkers for preeclampsia.
- These genes may play a significant role in PE development.
- Further research into ferroptosis mechanisms in PE is warranted.
Abstract:
Preeclampsia (PE) is the leading cause of maternal and fetal mortality and morbidity. Early and accurate diagnosis is critical to reduce mortality. Placental oxidative stress has been identified as a major pathway to the development of PE. Ferroptosis, a new form of regulated cell death, is associated with iron metabolism and oxidative stress, and has been suspected to play a role in the pathophysiology of PE, although the mechanism is yet to be elucidated. The identification of potential ferroptosis-related biomarkers is of great significance for the early diagnosis and treatment of PE. A gene expression dataset of peripheral blood samples was downloaded from the Gene Expression Omnibus (GEO) dataset. Differentially expressed genes (DEGs) were filtrated with the R package “limma”. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of the DEGs were then conducted. Ferroptosis-related DEGs were screened by overlapping the ferroptosis-related genes with DEGs. The protein−protein interaction (PPI) network was used to identify the key ferroptosis-related DEGs. Enzyme-linked immunosorbent assay (ELISA) was used to validate changes in the selected key ferroptosis-related DEGs. The correlations between the key genes and clinical and pathological characteristics were analyzed. Finally, the diagnostic value of these key genes for PE was confirmed by a receiver operating characteristic (ROC) curve. A total of 5913 DEGs were identified and 45 ferroptosis-related DEGs were obtained. Besides, ferroptosis-related pathways were enriched by KEGG using DEGs. The PPI network showed that p53 and c-Jun were the critical hub genes. ELISA showed that p53 in the serum of PE patients was higher than that of the control group, while c-Jun was lower than that of the control group. Analysis of the clinicopathological features showed that p53 and c-Jun were correlated with the PE characteristics. Finally, based on the area under curve (AUC) values, c-Jun had the superior diagnostic power (AUC = 0.87, p < 0.001), followed by p53 (AUC = 0.75, p < 0.001). Our study identified that two key genes, p53 and c-Jun, might be potential diagnostic biomarkers of PE.
More Related Videos
05:30Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
Published on: November 8, 2024
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024